Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion. (Q33491075)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion. |
scientific article |
Statements
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion (English)
H A Burris
A Awada
J G Kuhn
J R Eckardt
P W Cobb
D A Rinaldi
S Fields
L Smith